注册证有效期与续证:3 年有效期与 6 个月启动线
Updated: 2026-11-09 · GRZAN Regulatory Team · Verification date 2026-10-20
I. Key takeaways
A Cambodian medical device registration certificate is valid for 3 years (counted from the date of issue); renewal must start 6 months before expiry and is handled by resubmitting an application (with updated documentation).
On validity, published sources conflict: most sources (including government-level country profiles) agree on 3 years; some commercial sources state 5 years, but the same sources also misstate the Cambodian classification as “Class I/II/III”, which undermines their credibility. GRZAN adopts 3 years and does not adopt 5 years.
To be clear: the 3-year validity and the 6-month start line cannot be located verbatim in officially readable texts; they are a practical interpretation, and the DDF’s current requirements prevail.
GRZAN note: validity is 3 years (5 years is not adopted); the renewal start line is 6 months before expiry; renewal is by resubmission (1 completely new filing, not a simple extension stamp).
II. Legal basis
| Regulation | Reference No. | Date | Provisions |
|---|---|---|---|
| Prakas No. 1258 on the Registration of Medical Devices | Prakas No. 1258 | 8 November 2012 | Certificate validity and renewal (article text not obtained; practical interpretation) |
| Government-level country profile: Cambodia medical device market and regulatory overview | Government-level country profile | — | The registration certificate is valid for 3 years from the date of issue; a renewal application must be filed 6 months before expiry (Grade B) |
| ASEAN Medical Device Directive (AMDD) | Signed by the 10 ASEAN member states | Article 22: entered into force on 1 January 2015 | Article 1.2 (registration obligation) |
III. Expert commentary
- “Renewal = new application” changes the workload model. In most markets renewal means submitting updated documents and paying a fee; Cambodia requires it to be processed as a new application, so the workload approaches a full submission — including fresh valid ISO/GMP certificates, a Certificate of Free Sale (CFS), the LoA and the DoC, and a fresh notarisation and consular legalisation chain. Treating renewal as “a simple extension” is the most common failure point in the second cycle.
- The 6-month start line is especially tight in Cambodia. With the committee sitting roughly every 3 to 4 months, 6 months covers only two windows. If the first submission slips, the certificate may lapse before renewal is complete. In addition to the 6-month start line, reserve a further 3 to 4 months for internal preparation.
- Lapse means a direct halt: no import, no sale. Importing product while the certificate has lapsed falls within the penalties discussed in article 40. For companies with steady shipments, renewal is not an administrative matter but a supply chain continuity matter.
IV. Practical recommendations
- Run renewal as a two-stage process: internal preparation from 12 months before expiry, formal submission at 6 months before expiry. Use the first 6 months to refresh certificates and redo notarisation and legalisation, and the second 6 months for review and window waiting.
- Drive the renewal package from the “certificate validity matrix”. Reuse the matrix built in article 15 at renewal, confirming item by item which certificates must be reissued.
- Set the renewal reminder on the day the certificate is obtained. Set reminders on both the local entity and the overseas manufacturer sides so no single memory point is relied on.
V. Verification checklist
- □ Certificate validity entered in the project calendar as 3 years (5-year claim not adopted)
- □ Reminder set for internal preparation from 12 months before expiry
- □ Renewal documentation prepared to the “fresh application” standard
- □ Certificate validity matrix updated to the renewal point
- □ Reissue and legalisation of ISO/GMP, CFS, LoA and DoC completed
- □ Supply chain disruption risk from certificate lapse assessed
Regulatory information verified as of 29 October 2026.
In Southeast Asia, GRZAN’s core capabilities focus on three areas. First, tracking the legislative progress of dedicated medical device laws across member states: Singapore, Malaysia, Thailand, Indonesia, the Philippines and Vietnam have each established written device regulatory frameworks, while Cambodia still has no dedicated Medical Device Law; the current rules are pieced together from three layers — the registration-number legal basis provided by the 1996 Law on the Management of Pharmaceuticals and its 2007 Amendment Law, the classification and procedures provided by Prakas No. 1258 of 2012, and the technical framework provided by the ASEAN Medical Device Directive (AMDD) — so compliance certainty is markedly lower than in markets that have completed legislation. Second, local authorised representative services: GRZAN acts as the manufacturer’s statutory representative in Cambodia, handling registration submissions, regulatory communication and post-market reporting obligations, and helping resolve the practical issues of the Cambodian registered pharmacist and the Import-Export Pharmaceutical Company Licence. Third, quality system and testing support: establishing a quality management system conforming to ISO 13485 and organising the technical dossier under the ASEAN Common Submission Dossier Template (CSDT).
Business enquiries: info@grzanglobal.com
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us